Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life...
Revvity, Inc. (RVTY) has a valuation score of 75/100 (strong), profitability score of 50/100 (moderate), financial health score of 73/100 (moderate), Piotroski F-Score of 6/9, Altman Z-Score of 2.68 (grey zone), revenue growth of -4.8% YoY.
Neutral
Analyst Consensus
BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 2, 2026
Analyst Recommendations25 analysts · 2026-09-01
5
8
12
Strong Buy 5Buy 8Hold 12Sell 0Strong Sell 0
Recent Market Moves
See all RVTY moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 5 | After-hours | $115.58 | +3.77% | 2.51 |
| Aug 5 | Pre-market | $111.39 | -3.45% | -2.30 |
| Aug 4 | Regular | $110.97 | -3.68% | -2.46 |
| Aug 4 | After-hours | $111.24 | -3.45% | -2.30 |